PAVMW Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (28 Jan 2022 @ 12:36):

Stats
Today's Volume	32 626
Average Volume	6 563
Market Cap	769 747
EPS	$-1.750 ( Q1 \| 2024-05-13 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.0500 (Sector) 42.63 (Industry) 43.86
ATR14	$0.0950 (327.59%)

ABMD 0.00%

AMIX -4.95%

BBLGW -21.85%

BVS 0.52%

COCH 3.06%

DHAI -3.26%

DHAIW -22.93%

DNAY 8.33%

EYES -5.05%

GBS -1.58%

HSCS -1.70%

HSCSW -32.26%

IINNW 1.61%

INVO -3.33%

LFWD 1.26%

MDAI -2.22%

MGRM 3.86%

MXCT -2.00%

NVNOW -32.98%

NXL -42.91%

NXLIW -15.00%

OSA -7.35%

OSAAW -6.40%

PAVMW 105.67%

PAVMZ 0.00%

PETVW 0.00%

QTI 2.21%

QTNT 0.00%

Volume Correlation

Long: -0.02 (neutral)

Short: -0.15 (neutral)

Signal:(30.313) Neutral

PAVmed Inc. Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

PAVmed Inc. Correlation - Currency/Commodity

0.78
( moderate )

-0.46
( neutral )

-0.05
( neutral )

0.17
( neutral )

0.59
( weak )

-0.63
( weak negative )

PAVmed Inc. Financials

Annual	2023
Revenue:	$2.45M
Gross Profit:	$-6.90M (-281.40 %)
EPS:	$-8.87

FY	2023
Revenue:	$2.45M
Gross Profit:	$-6.90M (-281.40 %)
EPS:	$-8.87

FY	2022
Revenue:	$377 000
Gross Profit:	$-3.24M (-858.62 %)
EPS:	$-17.06

FY	2021
Revenue:	$500 000
Gross Profit:	$-85 000.00 (-17.00 %)
EPS:	$-1.897

Financial Reports:

No articles found.

PAVmed Inc. Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

PAVmed Inc.

PAVmed Inc. operates as a medical device company in the United States. The company\'s lead products include CarpX, a percutaneous device to treat carpal tunnel syndrome; and EsoCheck, an esophageal cell collection device for the early detection of adenocarcinoma of the esophagus and Barrett\'s Esophagus (BE). Its product pipeline also comprises EsoGuard, a molecular diagnostic esophageal DNA test; EsoCure, an esophageal ablation device to treat dysplastic BE; PortIO, an implantable intraosseous vascular access device; NextFlo, a disposable infusion platform technology; PortIO, an implantable intraosseous vascular access device; and DisappEAR, a resorbable pediatric ear tube, as well as NextCath and Caldus. The company was formerly known as PAXmed Inc. and changed its name to PAVmed Inc. in April 2015. PAVmed Inc. was incorporated in 2014 and is based in New York, New York.